Sponsor Pipeline

Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd. Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
14
Active Trials
8
Recruiting
6
Phase 3
7
Disease Areas
1
Changes, 30 Days
What Changed in the Last 30 Days
DetectedTrialChange
2026-08-07 NCT07730190
A Clinical Trial of TQB6426 for Injection in Patients With Advanced Solid Tumors
Trial sites expanded: 1 -> 8 locations
New Trial Filings, Last 30 Days
First PostedTrialPhaseStatus
2026-07-28 NCT07730190 A Clinical Trial of TQB6426 for Injection in Patients With Advanced Solid Tumors Phase 1 Not Yet Recruiting
Active Trials by Phase
Phase 3
6
Phase 2
3
Phase 1/2
2
Phase 1
3
Active Trials
NCT IDTitleConditionStatus
Phase 3
NCT07107256 Clinical Trial of TQC2731 Injection in Patients With Chronic Sinusitis and Nasal Polyps Chronic Rhinosinusitis With Nasal Polyps (CRSwNP) Recruiting
NCT07165951 Clinical Trial Comparing TQB2868 Injection Combined With Anlotinib Hydrochloride Capsules… Metastatic Pancreatic Ductal Adenocarcinoma Recruiting
NCT06829784 TQC2731 Clinical Trial for the Treatment of Severe Asthma With Injection Asthma Recruiting
NCT07385703 Clinical Study on the Efficacy and Safety of LM-302 Injection Combined With Tislelizumab… Adenocarcinoma Recruiting
NCT07187960 Evaluation of the Efficacy and Safety of TQB2825 Injection Compared to Immunotherapy in… Follicular Lymphoma Not Yet Recruiting
NCT06552520 To Evaluate the Phase III Clinical Trial of TQH2722 Injection in the Treatment of… Atopic Dermatitis Active, Not Recruiting
Phase 2
NCT06854445 Clinical Trial of TQB2825 Injection Combined With Chemotherapy in Subjects With Diffuse… Diffuse Large Cell B-lymphoma Recruiting
NCT07398859 Clinical Study on TQH2722 Injection Combined With Background Therapy for Seasonal… Seasonal Allergic Rhinitis Recruiting
NCT06707883 A Clinical Study of TQC2731 Injection in Patients With Moderate to Severe Chronic… Chronic Obstructive Pulmonary Disease Active, Not Recruiting
Phase 1/2
NCT07266116 Assessment of the Efficacy and Safety of Injectable TQB2934 (Subcutaneous Injection) in… Systemic Light Chain Amyloidosis Recruiting
NCT07601204 Treatment of Recurrent/Metastatic Head and Neck Cancer Recurrent/Metastatic Head and Neck Cancer Not Yet Recruiting
Phase 1
NCT07260708 Clinical Trial of TQB2922 Injection (Subcutaneous Injection) in Patients With Advanced… Advanced Cancers Recruiting
NCT07110194 Phase I Clinical Trial of TQB2825 Subcutaneous Injection in CD20-positive Hematological… CD20-positive Hematological Malignancies Not Yet Recruiting
NCT07730190 A Clinical Trial of TQB6426 for Injection in Patients With Advanced Solid Tumors Advanced Malignancies Not Yet Recruiting
Disease Areas
Get alerts when Shanghai Chia Tai Tianqing Pharmaceutical Technology Development Co., Ltd.'s trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free